-
IDNA Dashboard
- Holdings
iShares Genomics Immunology and Healthcare ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
BlackRock Cash Funds: Institutional, SL Agency Shares | 19.89 mm | 19.88 mm shares | 14.44 | Short-term investment vehicle | Long | USA |
EXEL Exelixis, Inc. | 8.45 mm | 254.46 k shares | 6.13 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 7.64 mm | 86.05 k shares | 5.55 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 7.38 mm | 138.02 k shares | 5.36 | Common equity | Long | USA |
BeiGene Ltd
|
7.18 mm | 456.10 k shares | 5.21 | Common equity | Long | Cayman Islands |
INCY Incyte Corporation | 6.98 mm | 94.11 k shares | 5.06 | Common equity | Long | USA |
Roche Holding AG
|
6.38 mm | 20.58 k shares | 4.63 | Common equity | Long | Switzerland |
BNTX BioNTech SE | 6.28 mm | 55.49 k shares | 4.56 | Common equity | Long | Germany |
Sanofi SA
|
5.97 mm | 56.51 k shares | 4.33 | Common equity | Long | France |
Takeda Pharmaceutical Co Ltd
|
5.75 mm | 206.10 k shares | 4.17 | Common equity | Long | Japan |
SRPT Sarepta Therapeutics, Inc. | 5.69 mm | 45.15 k shares | 4.13 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 5.25 mm | 62.36 k shares | 3.81 | Common equity | Long | USA |
GSK PLC
|
4.85 mm | 268.66 k shares | 3.52 | Common equity | Long | UK |
REGN Regeneron Pharmaceuticals, Inc. | 4.65 mm | 5.55 k shares | 3.38 | Common equity | Long | USA |
Genmab A/S
|
4.46 mm | 19.91 k shares | 3.24 | Common equity | Long | Denmark |
MRK Merck & Co., Inc. | 4.36 mm | 42.61 k shares | 3.16 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 3.63 mm | 348.09 k shares | 2.64 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 3.50 mm | 86.64 k shares | 2.54 | Common equity | Long | USA |
GERN Geron Corporation | 3.20 mm | 779.09 k shares | 2.32 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 3.09 mm | 102.43 k shares | 2.24 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals Incorporated | 2.89 mm | 27.33 k shares | 2.10 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 2.62 mm | 119.54 k shares | 1.90 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 2.47 mm | 308.45 k shares | 1.79 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 2.40 mm | 202.28 k shares | 1.74 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 2.17 mm | 88.42 k shares | 1.58 | Common equity | Long | USA |
MRNA Moderna, Inc. | 2.00 mm | 36.87 k shares | 1.45 | Common equity | Long | USA |
NVAX Novavax, Inc. | 1.99 mm | 207.49 k shares | 1.45 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 1.87 mm | 21.37 k shares | 1.36 | Common equity | Long | USA |
Ono Pharmaceutical Co Ltd
|
1.46 mm | 116.90 k shares | 1.06 | Common equity | Long | Japan |
CRISPR Therapeutics AG
|
1.31 mm | 28.19 k shares | 0.95 | Common equity | Long | Switzerland |
ABLBio Inc
|
1.29 mm | 48.01 k shares | 0.94 | Common equity | Long | Korea, Republic of |
IBRX ImmunityBio, Inc. | 1.25 mm | 240.01 k shares | 0.91 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 1.14 mm | 74.67 k shares | 0.83 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 1.03 mm | 137.97 k shares | 0.75 | Common equity | Long | USA |
ABCL AbCellera Biologics Inc. | 876.38 k | 321.02 k shares | 0.64 | Common equity | Long | Canada |
Arcturus Therapeutics Holdings, Inc. | 677.69 k | 38.22 k shares | 0.49 | Common equity | Long | USA |
OABI OmniAb, Inc. | 604.55 k | 147.81 k shares | 0.44 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 541.56 k | 67.61 k shares | 0.39 | Common equity | Long | USA |
Valneva SE
|
470.90 k | 166.56 k shares | 0.34 | Common equity | Long | France |
NTLA Intellia Therapeutics, Inc. | 468.95 k | 32.98 k shares | 0.34 | Common equity | Long | USA |
XNCR Xencor, Inc. | 436.59 k | 20.78 k shares | 0.32 | Common equity | Long | USA |
uniQure NV
|
424.17 k | 74.16 k shares | 0.31 | Common equity | Long | Netherlands |
DNA Ginkgo Bioworks Holdings, Inc. | 415.75 k | 54.56 k shares | 0.30 | Common equity | Long | USA |
CureVac NV
|
399.36 k | 145.75 k shares | 0.29 | Common equity | Long | Netherlands |
EDIT Editas Medicine, Inc. | 370.14 k | 127.63 k shares | 0.27 | Common equity | Long | USA |
ToolGen Inc
|
362.82 k | 8.95 k shares | 0.26 | Common equity | Long | Korea, Republic of |
MGNX MacroGenics, Inc. | 331.06 k | 90.45 k shares | 0.24 | Common equity | Long | USA |
BlackRock Cash Funds: Treasury, SL Agency Shares | 240.00 k | 240.00 k shares | 0.17 | Short-term investment vehicle | Long | USA |
Nxera Pharma Co Ltd
|
205.97 k | 25.80 k shares | 0.15 | Common equity | Long | Japan |
OABI OmniAb, Inc. | 0.19 | 19.50 k shares | 0.00 | Common equity | Long | USA |
OABI OmniAb, Inc. | 0.19 | 19.50 k shares | 0.00 | Common equity | Long | USA |
XAV HEALTH CARE DEC24 | -27.00 k | 3.00 contracts | -0.02 | Equity derivative | N/A | USA |